13F HOLDINGS REPORT
Logos Global Management LP
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0001172661-23-002203
Total Value
$698.7M
Positions
43
Other Managers
0
Confidential Omitted
No
Holdings (43)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | APELLIS PHARMACEUTICALS INC | APLS | 800,000 | $52.8M | 7.55% |
| 2 | IDEAYA BIOSCIENCES INC | IDYA | 3,600,000 | $49.4M | 7.07% |
| 3 | CYTOKINETICS INC | CYTK | 1,250,000 | $44.0M | 6.30% |
| 4 | IMMUNOVANT INC | IMVT | 2,500,000 | $38.8M | 5.55% |
| 5 | IVERIC BIO INC | 46583P102 | 1,520,000 | $37.0M | 5.29% |
| 6 | XENON PHARMACEUTICALS INC | XENE | 900,000 | $32.2M | 4.61% |
| 7 | SAREPTA THERAPEUTICS INC | SRPT | 220,000 | $30.3M | 4.34% |
| 8 | BIOGEN INC | BIIB | 100,000 | $27.8M | 3.98% |
| 9 | IMMUNOCORE HLDGS PLC | IMCR | 500,000 | $24.7M | 3.54% |
| 10 | ALLAKOS INC | 01671P100 | 5,536,666 | $24.6M | 3.53% |
| 11 | VIRIDIAN THERAPEUTICS INC | VRDN | 950,000 | $24.2M | 3.46% |
| 12 | NEUROCRINE BIOSCIENCES INC | NBIX | 200,000 | $20.2M | 2.90% |
| 13 | DYNE THERAPEUTICS INC | DYN | 1,700,000 | $19.6M | 2.80% |
| 14 | KARUNA THERAPEUTICS INC | 48576A100 | 100,000 | $18.2M | 2.60% |
| 15 | DESIGN THERAPEUTICS INC | DSGN | 2,797,501 | $16.1M | 2.31% |
| 16 | ASCENDIS PHARMA A/S | ASND | 150,000 | $16.1M | 2.30% |
| 17 | BICYCLE THERAPEUTICS PLC | BCYC | 750,000 | $16.0M | 2.28% |
| 18 | ROCKET PHARMACEUTICALS INC | RCKTW | 900,000 | $15.4M | 2.21% |
| 19 | AKERO THERAPEUTICS INC | 00973Y108 | 400,000 | $15.3M | 2.19% |
| 20 | BIOMARIN PHARMACEUTICAL INC | BMRN | 150,000 | $14.6M | 2.09% |
| 21 | ASTRIA THERAPEUTICS INC | 04635X102 | 1,044,960 | $13.9M | 1.99% |
| 22 | GALAPAGOS NV | GLPGF | 350,000 | $13.5M | 1.94% |
| 23 | OLEMA PHARMACEUTICALS INC | OLMA | 3,743,875 | $13.0M | 1.86% |
| 24 | MADRIGAL PHARMACEUTICALS INC | MDGL | 50,000 | $12.1M | 1.73% |
| 25 | DICE THERAPEUTICS INC | 23345J104 | 410,000 | $11.7M | 1.68% |
| 26 | DISC MEDICINE INC | IRON | 525,000 | $11.1M | 1.59% |
| 27 | COGENT BIOSCIENCES INC | COGT | 1,000,000 | $10.8M | 1.54% |
| 28 | BIOHAVEN LTD | BHVN | 700,000 | $9.6M | 1.37% |
| 29 | VENTYX BIOSCIENCES INC | 92332V107 | 270,000 | $9.0M | 1.29% |
| 30 | ENLIVEN THERAPEUTICS INC | ELVN | 401,229 | $8.8M | 1.26% |
| 31 | STRUCTURE THERAPEUTICS INC | GPCR | 350,000 | $8.3M | 1.19% |
| 32 | GERON CORP | GERN | 3,550,000 | $7.7M | 1.10% |
| 33 | ALX ONCOLOGY HLDGS INC | ALXO | 1,500,000 | $6.8M | 0.97% |
| 34 | MORPHOSYS AG | 617760202 | 1,500,000 | $5.9M | 0.85% |
| 35 | FIBROGEN INC | 31572Q808 | 300,000 | $5.6M | 0.80% |
| 36 | MINERALYS THERAPEUTICS INC | MLYS | 300,000 | $4.7M | 0.67% |
| 37 | CYMABAY THERAPEUTICS INC | 23257D103 | 400,000 | $3.5M | 0.50% |
| 38 | VIGIL NEUROSCIENCE INC | 92673K108 | 188,390 | $1.8M | 0.26% |
| 39 | TYRA BIOSCIENCES INC | TYRA | 87,673 | $1.4M | 0.20% |
| 40 | ALIGOS THERAPEUTICS INC | ALGS | 1,000,000 | $874,000 | 0.13% |
| 41 | IMMUNIC INC | IMUX | 421,184 | $627,564 | 0.09% |
| 42 | LIANBIO | LIANY | 280,000 | $548,800 | 0.08% |
| 43 | NUVATION BIO INC | NUVB | 66,666 | $8,000 | 0.00% |